Anemia in Infancy

Total Page:16

File Type:pdf, Size:1020Kb

Anemia in Infancy in brief In Brief Anemia in Infancy Jennifer Cobelli Kett, MD cells that express embryonic hemoglo- Blood loss, a common cause of anemia Children’s National Medical Center bin. At 6 weeks’ gestation, the liver be- in the neonatal period, may be acute or Washington, DC comesthepredominantsiteofRBC chronic and can result from umbilical production, and the cells produced pri- cord abnormalities, placenta previa, pla- marily express fetal hemoglobin. Not until cental abruption, traumatic delivery, or Author Disclosure 6 months’ gestation does the bone mar- internal bleeding in the infant. In one-half Dr Kett has disclosed no financial row become the major site of hematopoi- of all pregnancies, fetal–maternal hemor- relationships relevant to this article. esis. Throughout fetal life, erythrocytes rhage can be demonstrated by the iden- This commentary does not contain decrease in size and increase in number: tificationoffetalcellsinthematernal hematocrit increases from 30% to 40% circulation. Blood also can be transfused a discussion of an unapproved/ during the second trimester to 50% to from one fetus to another in monochor- investigative use of a commercial 63% at term. In late gestation and after ionic twin gestations. In some pregnan- product/device. birth, RBCs gradually switch from the cies, these losses can be severe. production of fetal hemoglobin to adult The accelerated destruction of RBCs hemoglobin. may be either immune or nonimmune Anemia and Pallor. Kolb EA, Levy AS. In: After birth, RBC mass normally de- mediated. Isoimmune hemolytic anemia McInerny TK, Adam HM, Campbell DE, clines in response to an increase in the is caused by ABO, Rh, or minor blood Kamat DM, Kelleher KJ, eds. American availability of oxygen and downregu- group incompatibility between the Academy of Pediatrics Textbook of lation of erythropoietin. RBC count mother and fetus. Maternal immuno- Pediatric Care. Elk Grove Village, IL: decreases until oxygen delivery is inade- globulin G antibodies to fetal antigens American Academy of Pediatrics; quate for metabolic demand and eryth- can cross the placenta and enter the 2009:1395–1405 Diseases of the Blood. In: Behrman RE, ropoietin production is stimulated again. fetal bloodstream, causing hemolysis. Kliegman RM, Jenson HB, eds. Nelson In healthy term infants, the RBC nadir, These disorders have a wide clinical Textbook of Pediatrics. 17th ed. a physiologic response to postnatal spectrum, ranging from mild, self-limited Philadelphia, PA: Saunders; 2004: life and not a hematologic disorder, hemolytic anemias to lethal hydrops fe- 1599–1678 typically occurs at 8 to 12 weeks of talis. Because maternal antibodies may The Blood and Hematopoietic System. life and at a hemoglobin level of 9 to take months to clear, affected infants In: Martin RJ, Fanaroff AA, Walsh MC, 11 g/dL. can experience prolonged hemolysis. eds. Fanaroff and Martin’s Neonatal- Preterm infants also experience a de- ABO incompatibility usually occurs Perinatal Medicine: Diseases of the crease in hemoglobin concentration af- when type O mothers carry fetuses that Fetus and Infant. 8th ed. Philadelphia, ter birth, with a decline that typically is are type A or B. Because A and B anti- PA: Mosby; 2006:1287–1356 more abrupt and more profound than in gens are widely distributed in the body, term infants, reaching hemoglobin lev- ABO incompatibility typically is less se- Anemia is the reduction in red blood cell els of 7 to 9 g/dL at 3 to 6 weeks of age. vere than Rh disease and is not affected (RBC) number, hematocrit, or hemoglobin This anemia of prematurity is likely the by birth order. In contrast, Rh hemolytic concentration to a value >2SDsbelow result of lower hemoglobin levels at disease occurs infrequently during the the age-specific mean. Anemia in infancy, birth, decreased RBC lifespan, and a first pregnancy because sensitization which may result from increased erythro- suboptimal erythropoietin response, and typically is caused by maternal exposure cyte loss or inadequate RBC production, may be more pronounced in the smallest to Rh-positive fetal cells around the time raises unique considerations. and most premature infants. Anemia of of delivery. With the widespread use of Understanding the development of prematurity may be exaggerated by non- Rh immunoglobulin, life-threatening Rh the hematopoietic system may be help- physiologic factors, including frequent incompatibility is now rare. ful in the evaluation of neonates with blood sampling for laboratory tests, and Abnormalities of RBC structure, en- anemia. Erythropoiesis begins in the yolk may be accompanied by significant clin- zyme activity, or hemoglobin produc- sac at 2 weeks’ gestation, generating ical symptoms. tion also can cause hemolytic anemia 186 Pediatrics in Review Vol.33 No.4 April 2012 in brief because the abnormal cells are removed are normal or slightly increased. Fanconi physical examination, with special at- more rapidly from the circulation. He- anemia is a congenital syndrome of bone tention to cardiovascular status, jaun- reditary spherocytosis is one such disor- marrow failure, although it is often un- dice, organomegaly, and any physical der, caused by a cytoskeletal protein recognized until later in childhood. Other anomalies. The initial laboratory evalua- defect that results in fragile, inflexible congenital anemias include the congen- tion should include a complete blood cells. Glucose-6-phosphate dehydroge- ital dyserythropoietic anemias and the count with red cell indices, a reticulocyte nase deficiency, an X-linked enzyme sideroblastic anemias. count, a peripheral blood smear, and di- disorder, typically causes an episodic Iron deficiency is a common cause rect antiglobulin test (Coombs’ test). hemolytic anemia that occurs in re- of microcytic anemia in infants and These results may help to direct addi- sponse to infection or oxidant stress. children, and it typically peaks at 12 tional testing. Treatment will be guided The thalassemias are hereditary disor- to 24 months of age. Preterm infants by the clinical severity of the anemia ders caused by defects in hemoglobin have less stored iron and may become and the underlying illness. Transfu- synthesis and are classified as alpha deficient earlier. Infants who experi- sions may be required to restore ade- or beta according to the affected globin ence increased iron loss from frequent quate tissue oxygenation and expand chain. They range in severity from silent laboratory sampling, surgical procedures, circulating blood volume, and certain carrier states to fatal hydrops fetalis, hemorrhage, or anatomic abnormalities clinical conditions may require exchange depending on the type of thalassemia, also may become deficient sooner. In- transfusion. number of affected genes, amount of testinal blood loss caused by exposure globin production, and ratio of alpha- to cow milk also may place infants at Comments: Prematurely born in- to beta-globin produced. higher risk. Lead poisoning can be the fants are at particular risk for iron defi- Sickle cell anemia is another disor- cause of a microcytic anemia similar to ciency because they have not had the der of hemoglobin production. Children iron deficiency anemia. benefit of a full third trimester of ges- born with sickle trait are largely unaf- Both vitamin B12 and folate defi- tation, during which an infant born at fected, whereas those who have sickle ciency can cause macrocytic anemia. term has been able to leach from the cell disease may experience hemolytic Because human milk, pasteurized cow mother (unless she is severely depleted) anemia associated with a wide range milk, and infant formulas provide suf- enough iron to maintain sufficiency un- of clinical effects. The onset of symptoms ficient folic acid, a deficiency of this til the infant has slightly more than occurs as the amount of fetal hemo- vitaminisuncommonintheUnited doubled his or her birth weight. Full- globin declines and abnormal hemo- States. Of note, goat milk is not an ad- term infants, unless they are actively globin S rises, typically after 4 months equate source of folate. Vitamin B12 de- losing blood, are not at high risk for of age. ficiency also is rare but may occur in iron-deficiency anemia in the first Infants and young children may ex- human milk–fed infants born to moth- months of age, but premature infants perience serious bacterial infections, ers with low B12 stores, especially those with their insufficient iron stores cer- dactylitis, hepatic or splenic sequestra- who follow strict vegan diets or have tainly are. tion, aplastic crises, vaso-occlusive cri- pernicious anemia. Malabsorptive syn- What is even more significant is the ses, acute chest syndrome, priapism, dromes, necrotizing enterocolitis, and fact that when the body is depleted of stroke, and other complications. Other other intestinal anomalies may put in- iron stores, the consequences go be- hemoglobinopathies include hemoglo- fants at higher risk for these deficien- yond anemia. Iron is critical to a wide bin E, the most common hemoglobinop- cies, as can certain drugs or congenital range of physiologic functions beyond athy worldwide. Hemolytic anemia also disorders. hemoglobin’s role as a carrier of oxygen. can be caused by infection, hemangio- Other disorders of inadequate RBC Mitochondrial electron transport, neu- mas, vitamin E deficiency, and dissemi- production may be the result of chronic rotransmitter function, and detoxifica- nated intravascular coagulation, among disease, infection, malignancy, or tran- tion, as well
Recommended publications
  • Very Low Birth Weight Infants
    Intensive Care Nursery House Staff Manual Very Low and Extremely Low Birthweight Infants INTRODUCTION and DEFINITIONS: Low birth weight infants are those born weighing less than 2500 g. These are further subdivided into: •Very Low Birth Weight (VLBW): Birth weight <1,500 g •Extremely Low Birth Weight (ELBW): Birth weight <1,000 g Obstetrical history (LMP, sonographic dating), newborn physical examination, and examination for maturational age (Ballard or Dubowitz) are critical data to differentiate premature LBW from more mature growth-retarded LBW infants. Survival statistics for ELBW infants correlate with gestational age. Morbidity statistics for growth-retarded VLBW infants correlate with the etiology and the severity of the growth-restriction. PREVALENCE: The rate of VLBW babies is increasing, due mainly to the increase in prematurely-born multiple gestations, in part related to assisted reproductive techniques. The distribution of LBW infants is shown in the Table: ________________________________________________________________________ Table. Prevalence by birth weight (BW) of LBW babies. Percentage of Percentage of Births Birth Weight (g) Total Births with BW <2,500 g <2,500 7.6% 100% 2,000-2,500 4.6% 61% 1,500-1,999 1.5% 20% 1,000-1,499 0.7% 9.5% 500-999 0.5% 7.5% <500 0.1% 2.0% ________________________________________________________________________ CAUSES: The primary causes of VLBW are premature birth (born <37 weeks gestation, and often <30 weeks) and intrauterine growth restriction (IUGR), usually due to problems with placenta, maternal health, or to birth defects. Many VLBW babies with IUGR are preterm and thus are both physically small and physiologically immature. RISK FACTORS: Any baby born prematurely is more likely to be very small.
    [Show full text]
  • Maternal and Fetal Outcomes of Spontaneous Preterm Premature Rupture of Membranes
    ORIGINAL CONTRIBUTION Maternal and Fetal Outcomes of Spontaneous Preterm Premature Rupture of Membranes Lee C. Yang, DO; Donald R. Taylor, DO; Howard H. Kaufman, DO; Roderick Hume, MD; Byron Calhoun, MD The authors retrospectively evaluated maternal and fetal reterm premature rupture of membranes (PROM) at outcomes of 73 consecutive singleton pregnancies com- P16 through 26 weeks of gestation complicates approxi- plicated by preterm premature rupture of amniotic mem- mately 1% of pregnancies in the United States and is associ- branes. When preterm labor occurred and fetuses were at ated with significant risk of neonatal morbidity and mor- tality.1,2 a viable gestational age, pregnant patients were managed Perinatal mortality is high if PROM occurs when fetuses aggressively with tocolytic therapy, antenatal corticos- are of previable gestational age. Moretti and Sibai 3 reported teroid injections, and antenatal fetal testing. The mean an overall survival rate of 50% to 70% after delivery at 24 to gestational age at the onset of membrane rupture and 26 weeks of gestation. delivery was 22.1 weeks and 23.8 weeks, respectively. The Although neonatal morbidity remains significant, latency from membrane rupture to delivery ranged despite improvements in neonatal care for extremely pre- from 0 to 83 days with a mean of 8.6 days. Among the mature newborns, neonatal survival has improved over 73 pregnant patients, there were 22 (30.1%) stillbirths and recent years. Fortunato et al2 reported a prolonged latent phase, low infectious morbidity, and good neonatal out- 13 (17.8%) neonatal deaths, resulting in a perinatal death comes when physicians manage these cases aggressively rate of 47.9%.
    [Show full text]
  • Use of Blood Components in the Newborn
    NNF Clinical Practice Guidelines Use of Blood Components in the Newborn Summary of recommendations • Transfusion in the newborn requires selection of appropriate donor, measures to minimize donor exposure and prevent graft versus host disease and transmission of Cytomegalovirus. • Component therapy rather than whole blood transfusion, is appropriate in most situations. • A clear cut policy of cut-offs for transfusions in different situations helps reduce unnecessary exposure to blood products. • Transfusion triggers should be based on underlying disease, age and general condition of the neonate. Writing Group : Chairperson: Arvind Saili ; Members: RG Holla, S Suresh Kumar Reviewers: Neelam Marwaha, Ruchi Nanawati Page | 129 Downloaded from www.nnfpublication.org NNF Clinical Practice Guidelines Introduction Blood forms an important part of the therapeutic armamentarium of the neonatologist. Very small premature neonates are amongst the most common of all patient groups to receive extensive transfusions. The risks of blood transfusion in today’s age of rigid blood banking laws, while infrequent, are not trivial. Therefore, as with any therapy used in the newborn, it is essential that one considers the risk- benefit ratio and strive to develop treatment strategies that will result in the best patient outcomes. In addition, the relatively immature immune status of the neonate predisposes them to Graft versus Host Disease (GVHD), in addition to other complications including transmission of infections, oxidant damage, allo- immunization and
    [Show full text]
  • Transitioning Newborns from NICU to Home: Family Information Packet
    Transitioning Newborns from NICU to Home Family Information Packet Your Health Coach has prepared this information packet for your family to help explain the medical needs of your newborn as you prepare to leave the hospital. A Health Coach helps families/ caregivers adjust to working directly with the health care providers as well as increasing your ability and confidence to care for your infant. When infants are born before their due date or with health problems, families often need help managing their baby’s health care after leaving the hospital. Since they spend the first part of their lives in the hospital, the babies and their families may find it helpful to have extra support. Your Health Coach will work with your family to teach you to care for your infant, connect with the right doctors and specialists for treatment, and find resources in your area. The role of the Health Coach is as an educator, not as a caregiver. Planning must start before hospital discharge and continue through followup with the primary care provider. After discharge from the hospital, your infant’s care must be well coordinated and clearly communicated to avoid medical errors that could harm the baby. After your infant is discharged, your Health Coach should follow up with you by phone within a few days to make sure the transition is going well. Your Health Coach will want to know how your baby is doing, whether you have any questions or concerns, if your infant has been to the scheduled appointments, etc. This information packet contains tips for getting care, understanding signs and symptoms of illness, medicines and immunizations, managing breathing problems, and feeding.
    [Show full text]
  • Ped9. Perinatal Period.Pdf
    PERINATAL PERIOD Ped9 (1) Perinatal Period Last updated: April 21, 2019 DELIVERY ROOM ..................................................................................................................................... 1 EVALUATION ......................................................................................................................................... 1 POSTDELIVERY CARE .............................................................................................................................. 2 URINATION ............................................................................................................................................ 2 CIRCUMCISION ....................................................................................................................................... 2 DEFECATION .......................................................................................................................................... 2 PREMATURITY ......................................................................................................................................... 2 POSTDATISM, POSTMATURITY ................................................................................................................ 4 SMALL-FOR-GESTATIONAL-AGE (SGA, DYSMATURITY, INTRAUTERINE GROWTH RESTRICTION, IUGR) ...................................................................................................................................................... 4 LARGE-FOR-GESTATIONAL-AGE (LGA) ...............................................................................................
    [Show full text]
  • 6/11/2019 1 “Lab Called… Your CBC Clotted”
    6/11/2019 Neonatal Lab Interpretation Tanya Hatfield, MSN, RNC - NIC UCSF Benioff Children’s Outreach Services “Lab called… your CBC clotted” 2 Objectives ▪ Interpret lab values ▪ Discuss jaundice of the newborn ▪ Understand specific hematologic problems 3 1 6/11/2019 CBC - Hematopoiesis 4 Erythrocytes - RBCs ▪ Main protein is hemoglobin ( Hgb ) ▪ RBC function is to protect Hgb ▪ Hgb function is oxygen/CO2 transport Reticulocytes ▪ Inversely proportional to GA at birth ▪ Falls quickly to less than 2% by 7 days ▪ Elevated early Retic Ct may indicate bleeding, hemolysis or chronic blood loss 5 Kenner, C. (2014). Comprehensive neonatal nursing care (Fifth ed., pp. 334 - 338) Components of CBC ▪ Main protein is hemoglobin (Hgb) ▪ RBC function is to protect Hgb ▪ Hgb function is oxygen/CO2 transport Reticulocytes ▪ Inversely proportional to GA at birth ▪ Falls quickly to less than 2% by 7 days ▪ Elevated early Retic Ct may indicate bleeding, hemolysis or chronic blood loss 6 Kenner, C. (2014). Comprehensive neonatal nursing care (Fifth ed., pp. 334 - 338) 2 6/11/2019 RBC Indices ▪ Mean corpuscular volume (MCV): size and volume ▪ Mean corpuscular hemoglobin (MCH): average amount (weight) of hemoglobin ▪ Mean corpuscular hemoglobin concentration (MCHC): average concentration ▪ Nucleated RBC: circulating pre - reticulocyte 7 Kenner, C. (2014). Comprehensive neonatal nursing care (Fifth ed., pp. 334 - 338) Anemia ▪ Differential • ↓ Erythrocyte production ‒ infection, nutritional deficiencies, leukemia, bone marrow failure, anemia of prematurity
    [Show full text]
  • Pepid Pediatric Emergency Medicine Clinical Topics
    PEPID PEDIATRIC EMERGENCY MEDICINE CLINICAL TOPICS NEONATOLOGY • CEPHAL HEMATOMA • CYSTIC FIBROSIS • ABDOMINAL AND CHEST WALL • CEREBRAL PALSY • CYTOMEGALOVIRUS (CMV) DEFECTS (NEONATE AND INFANT) • CHRONIC NEONATAL LUNG • DELAYED TRANSITION • ABNORMAL HEAD SHAPE DISEASE • DRUG EXPOSED INFANT • ABO-INCOMPATIBILITY • COMNGENITAL PARVOVIRUS B 19 • ERYTHROBLASTOSIS FETALIS • ACNE - INFANTILE • CONGENITAL CANDIDIASIS • EXAMINATION OF THE NEWBORN • ALIGILLE SYNDROME • CONGENITAL CATARACTS • EXCHANGE TRANSFUSION • AMBIGUOUS GENITALIA • CONGENITAL CMV • EYE MISALIGNMENT • AMNIOTIC FLUID ASPIRATION • CONGENITAL COXSACKIEVIRUS • FETAL HYDRONEPHROSIS • ANAL ATRESIA • CONGENITAL DYSERYTHROPOIETIC • FETOMATERNAL TRANSFUSION • ANEMIA - SEVERE AT BIRTH ANEMIA • FFEDS/FLUIDS - PRETERM • ANEMIA OF PREMATURITY • CONGENITAL EMPHYSEMA • FPIES(FOOD PROTEIN INDUCED • ANHYDRAMNIOS SEQUENCE • CONGENITAL GLAUCOMA ENTEROCOLITIES SYNDROME) • APGAR SCORE • CONGENITAL GOITER • GASTRO INTESTINAL REFLUX • APNEA OF PREMATURITY • CONGENITAL HEART BLOCK • GROUP B STREPTOCOCCUS • APT TEST • CONGENITAL HEPATIC FIBROSIS • HEMORRHAGIC DISEASE OF THE • ASPHYXIATING THORACIC DYSTRO- • CONGENITAL HEPATITIS B NEWBORN PHY (JEUNE SYNDROME) INFECTION • HEPATIC RUPTURE • ATELECTASIS • CONGENITAL HEPTITIS C • HIV • ATRIAL SEPTAL DEFECTS INFECTION • HYALINE MEMBRANE DISEASE • BARLOW MANEUVER • CONGENITAL HYDROCELE • HYDROCEPHALUS • BECKWITH-WIEDEMANN SYN- • CONGENITAL HYPOMYELINATING • HYDROPS FETALIS DROME • CONGENITAL HYPOTHYROIDISM • HYPOGLYCEMIA OF INFANCY • BENIGN FAMILIAL NEONATAL
    [Show full text]
  • European Society for Paediatric Research Annual Meeting Abstracts Bilbao, Spain September 27–30, 2003
    0031-3998/03/5404-0557 PEDIATRIC RESEARCH Vol. 54, No. 4, 2003 Copyright © 2003 International Pediatric Research Foundation, Inc. Printed in U.S.A. EUROPEAN SOCIETY FOR PAEDIATRIC RESEARCH ANNUAL MEETING ABSTRACTS BILBAO, SPAIN SEPTEMBER 27–30, 2003 0008NEO 0011NEO PRESCHOOL OUTCOME IN CHILDREN BORN VERY PREMATURELY EFFICACY OF ERYTHROPOITIN IN PREMATURE INFANTS AND CARED FOR ACCORDING TO NIDCAP Adnan Amin, Daifulah Alzahrani Bjo¨rn Westrup1, Birgitta Bo¨hm1, Hugo Lagercrantz1, Karin Stjernqvist2 Alhada Military Hospital City:Taif, Saudi Arabia 1Neonatal Programme, Dept. of Woman and Child Health, Astrid Lindgren Children’s Hospital, Objective: To identify the effect of early of parentral recombinant human erythropoitin (r-HuEPO) Karolinska Institute, Stockholm, Sweden;2Depts. of Psychology and of Paediatrics, University of and iron administration on blood transfusion requirement of premature infants. Methods: In a Lund, Sweden City: Stockholm and Lund, Sweden controlled clinical trial conducted at the Neonatal Intensive Care Unit, Al-Hada Military Hospital, Background/aim: Care based on the Newborn Individualized Developmental Care and Assess- Taif, Kingdom of Saudi Arabia over a 16 month period. We assigned 20 very low birth weight infants ment Program (NIDCAP) has been reported to exert a positive impact on the development of (VLBW) with gestational age of (mean Ϯ SEM 28.4 Ϯ 0.5 weeks and birth weight of (mean Ϯ SEM prematurely born infants. The aim of the present investigation was to determine the effect of such care 1031 Ϯ 42 gm), to receive either intravenous (r-HuEPO 200 U/kg/day) and iron 1mg/kg/day or on the development at preschool age of children born with a gestational age of less than 32 weeks.
    [Show full text]
  • AAP-Section on Perinatal Pediatrics
    Abstracts &&&&&&&&&&&&&& AAP-Section on Perinatal Pediatrics 1. INTRACELLULAR ADHESION MOLECULE ONE (ICAM-1) IS expression of the inflammatory adhesion molecule, ICAM-1. This INCREASED IN THE CLARA CELL SECONDARY TO EXPOSURE TO supports the premise that the Clara cell may function to modulate LPS, TNF , AND HYPEROXIA pulmonary inflammation by either the secretion of the anti- W.D. Clark1, S.E. Welty2 and P.L. Ramsay3; 1Pediatrics, inflammatory protein, CCSP, or by the expression of the pro- Baylor College of Medicine, Houston, TX, 2Pediatrics, inflammatory protein, ICAM-1. These data further suggest that Children’s Research Institute, Columbus, OH, potential therapeutic interventions that modulate the gene expression 3Pediatrics and Molecular and Cell Biology, Baylor within the Clara cell may provide a method to regulate pulmonary College of Medicine, Houston, TX inflammation. Purpose. Early lung inflammation in prematurely born newborns 2. GENETIC ENHANCEMENT OF GLUTATHIONE REDUCTASE results from a variety of exposures, including cytokines and hyperoxia. Previously, we have shown that serum levels of the PROTECTS CHINESE HAMSTER OVARY CELLS FROM HYPOXANTHINE/ inflammatory adhesion molecule, ICAM-1, are higher in infants XANTHINE OXIDASE–MEDIATED OXIDANT STRESS that develop BPD than in infants that do not. In addition, the D.J. O’Donovan, R.C. Husser, T. Tamura and C.J. content of an anti-inflammatory tracheal fluid protein secreted by Fernandes; Pediatrics, Baylor College of Medicine, the Clara cell, the Clara cell secretory protein (CCSP), is decreased Houston, TX in infants that develop BPD, whereas others have shown that the level of tracheal fluid ICAM-1 is increased. Therefore, this study was Purpose.
    [Show full text]
  • Newnorn Babies (Nb)
    ا.د نعمان نافع الحمداني Professor Numan Nafie Hameed NEWNORN BABIES (NB) Neonatal period: It is the first 4 weeks of human life (28 days). It is divided into: Early Neonatal period: is the first week of life (7 days) Late Neonatal period: > 7- 28 days of life Perinatal mortality rate (PMR): Is the number of still born babies after 20 weeks of gestation + number of deaths in the first week of life per 1000 total births. Neonatal mortality rate (NMR): Is the number of infants died during the first 28 days of life per 1000 live births. NB by gestational age is classified as PRETERM: NB delivered before 37 completed weeks (<259 days). FULL TERM: NB delivered between 37-42 weeks (260- 294 days). POST TERM: NB delivered after 42 weeks (>295 days). NB gestational age is assessed by: 1. Obstetric information of LMP & EDD 2. Ultrasound examination (very accurate if obtained before 20 weeks' of gestation). 3. Fundal height by obstetrician 4. First reported heart sounds (10-12 weeks by Doppler ultrasound examination) 5. Date of first reported fetal activity (quickening usually occurs at 16-18 weeks) 6. Expanded new Ballard score NB by birth weight on growth charts is classified as: Small for gestational age (SGA) Is NB with birth weight of < 10 th centile 1 Appropriate for age (AGA) Is NB with birth weight between 10th -90th centiles Large for gestational age (LGA) Is NB with birth weight of > 90 th centile Full term neonates normally have the following: BW: Average 3.250 g (7.5 pounds), 95 % (2.500 – 4.250 g) Length: 50 cm, 95 % (46 – 56 cm) OFC 35 cm, 95 % (33 – 38 cm) Hb 14 – 22 g/ dl WBC 5000 - 20000 / cm3 BP 80/50 mm Hg RR 40 – 60 breaths/ minutes PR 120 – 160 beats / minutes Urine passed within 24 hours of birth, max.
    [Show full text]
  • Neonatal Transfusion Shan Yuan M.D
    Neonatal Transfusion Shan Yuan M.D. (Last Updated 4/18/2011) I. Anemia in a neonate: both physiological and iatrogenic (Note: unless otherwise noted, a “neonate” refers to an infant <4mo of age) A. Neonates typically undergo physiologic anemia of infancy due to reduced erythropoietin production, reaching a minimum Hgb of ~9g/dL around 10-12 weeks of age. This decline may occur earlier and faster in premature infants, reaching about 7g/dL or less. B. Anemia of prematurity is further exacerbated by laboratory draws during hospitalization C. In general, the smaller the neonate, the more likely transfusion would be needed. II. Pre-transfusion Testing A. Neonate‟s immune system not fully functional, almost all antibodies are of maternal origin at birth B. Usually a sample is drawn from both mom and infant to check for ABO/Rh type. Reverse type not done on the infant due to lack of endogenous ABO antibody production. C. Maternal serum checked also for unexpected non-ABO antibodies. o If negative: no additional compatibility testing (including crossmatching) is required during that hospital stay as long RBC given is group O negative, or ABO/Rh compatible with both mom and the infant o If positive for non-ABO alloantibodies: Can use maternal serum for subsequent compatibility testing Units negative for the appropriate antigen needs to be selected III. Selection and modification of blood products Age of the RBC Unit: o Ideally RBC units are less than 7-10 days of age(“fresh”) to avoid transfusing high levels of K+ and lactate. o This is less crucial in routine transfusions, but more so in massive transfusions (>15-20ml/kg of body weight) Aliquoting from designated unit o Aliquots of small volume transfusions can be removed from the same designated parent unit over days or weeks to reduce donor exposure over time.
    [Show full text]
  • Case Report of Anemia Following Fetal-Maternal Hemorrhage
    Katherine Newnam, PhD, RN, NNP-BC, CPNP, IBCLE, and ElizabethElizabeth Schierholz, Schierholz MSN,, MSN, NNP NNP ❍ Section ❍ Section Editor Editors Case of the Month Case Report of Anemia Following Fetal– Maternal Hemorrhage 06/14/2019 on flw5LIUrhNOxCqp8mpbW9RiCkSS4ziN2BS2bv+qEqdTyZzFEZZUsunYnemHEjVHIdWP5vIxRER9H3atwQQ0uBQ/yKYf2c17teA9PXFkSpxoy9lYQYJtBYg== by http://journals.lww.com/advancesinneonatalcare from Downloaded Kristi L. Coe, MSN, RNC-NIC, NNP-BC, CNS, CPNP Downloaded ABSTRACT from Background: Any maternal history of blood loss, ABO or Rh incompatibility, and hydrops fetalis often leads to suspicion http://journals.lww.com/advancesinneonatalcare of neonatal anemia postnatally. When maternal history consists only of decreased fetal movement, recognition of neo- natal anemia can be problematic. Clinical Findings: This case was a transported late preterm neonate who presented initially with persistent hypoxia unresponsive to usual respiratory support. On examination, mild paleness was noted. Primary Diagnosis: Anemia caused by fetal–maternal hemorrhage was the ultimate diagnosis confirmed by a Kleihauer- Betke test on maternal serum examining fetal cells. Interventions: Neonatal resuscitation included positive pressure ventilation, oxygen, and intubation. However, oxygen- ation did not improve prompting consultation with the neonatologist. Sedation and a paralytic were given. A chest radio- graph ruled out pneumothoraces and pleural effusions as causative. Initiation of inhaled nitric oxide produced a mild by flw5LIUrhNOxCqp8mpbW9RiCkSS4ziN2BS2bv+qEqdTyZzFEZZUsunYnemHEjVHIdWP5vIxRER9H3atwQQ0uBQ/yKYf2c17teA9PXFkSpxoy9lYQYJtBYg==
    [Show full text]